» Articles » PMID: 31261657

The Nucleoshuttling of the ATM Protein: A Unified Model to Describe the Individual Response to High- and Low-Dose of Radiation?

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2019 Jul 3
PMID 31261657
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

The evaluation of radiation-induced (RI) risks is of medical, scientific, and societal interest. However, despite considerable efforts, there is neither consensual mechanistic models nor predictive assays for describing the three major RI effects, namely radiosensitivity, radiosusceptibility, and radiodegeneration. Interestingly, the ataxia telangiectasia mutated (ATM) protein is a major stress response factor involved in the DNA repair and signaling that appears upstream most of pathways involved in the three precited RI effects. The rate of the RI ATM nucleoshuttling (RIANS) was shown to be a good predictor of radiosensitivity. In the frame of the RIANS model, irradiation triggers the monomerization of cytoplasmic ATM dimers, which allows ATM monomers to diffuse in nucleus. The nuclear ATM monomers phosphorylate the H2AX histones, which triggers the recognition of DNA double-strand breaks and their repair. The RIANS model has made it possible to define three subgroups of radiosensitivity and provided a relevant explanation for the radiosensitivity observed in syndromes caused by mutated cytoplasmic proteins. Interestingly, hyper-radiosensitivity to a low dose and adaptive response phenomena may be also explained by the RIANS model. In this review, the relevance of the RIANS model to describe several features of the individual response to radiation was discussed.

Citing Articles

Effects of Low Dose Neutron-Gamma Field on Cell Cycle and Damage of Human Lymphocytes.

Fu J, Du G, Wang H, Liao C, Zhang Y, Li W Dose Response. 2025; 23(1):15593258251323789.

PMID: 40034200 PMC: 11874152. DOI: 10.1177/15593258251323789.


Radiation symptoms resemble laminopathies and the physical underlying cause may sit at the lamin A C-terminus.

Waldherr A, Fogtman A Mol Med. 2025; 31(1):69.

PMID: 39979866 PMC: 11844092. DOI: 10.1186/s10020-025-01081-0.


Influence of the Nucleo-Shuttling of the ATM Protein on the Response of Skin Fibroblasts from Marfan Syndrome to Ionizing Radiation.

Jakubowska D, Al-Choboq J, Sonzogni L, Bourguignon M, Slonina D, Foray N Int J Mol Sci. 2024; 25(22).

PMID: 39596376 PMC: 11594578. DOI: 10.3390/ijms252212313.


Accelerated Aging Effects Observed In Vitro after an Exposure to Gamma-Rays Delivered at Very Low and Continuous Dose-Rate Equivalent to 1-5 Weeks in International Space Station.

Restier-Verlet J, Ferlazzo M, Granzotto A, Al-Choboq J, Bellemou C, Estavoyer M Cells. 2024; 13(20.

PMID: 39451221 PMC: 11506070. DOI: 10.3390/cells13201703.


Prediction of Cancer Proneness under Influence of X-rays with Four DNA Mutability and/or Three Cellular Proliferation Assays.

El Nachef L, Bodgi L, Estavoyer M, Bure S, Jallas A, Granzotto A Cancers (Basel). 2024; 16(18).

PMID: 39335159 PMC: 11430126. DOI: 10.3390/cancers16183188.


References
1.
Joiner M, Lambin P, Marples B . Adaptive response and induced resistance. C R Acad Sci III. 1999; 322(2-3):167-75. DOI: 10.1016/s0764-4469(99)80040-7. View

2.
Foray N, Randrianarison V, Marot D, Perricaudet M, Lenoir G, Feunteun J . Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2. Oncogene. 1999; 18(51):7334-42. DOI: 10.1038/sj.onc.1203165. View

3.
Barlow C, Ribaut-Barassin C, Zwingman T, Pope A, Brown K, Owens J . ATM is a cytoplasmic protein in mouse brain required to prevent lysosomal accumulation. Proc Natl Acad Sci U S A. 2000; 97(2):871-6. PMC: 15423. DOI: 10.1073/pnas.97.2.871. View

4.
Joiner M, Marples B, Lambin P, Short S, Turesson I . Low-dose hypersensitivity: current status and possible mechanisms. Int J Radiat Oncol Biol Phys. 2001; 49(2):379-89. DOI: 10.1016/s0360-3016(00)01471-1. View

5.
Baria K, Warren C, Roberts S, West C, Scott D . Chromosomal radiosensitivity as a marker of predisposition to common cancers?. Br J Cancer. 2001; 84(7):892-6. PMC: 2363837. DOI: 10.1054/bjoc.2000.1701. View